Background illustration for clinical trials search

Paid Clinical Trials Saint Paul

Discover 1,003 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

for
Niemann-Pick Type C Disease
Location: Minneapolis MN, Rochester MN, Dallas TX, Fairfax VA,
Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07082725

Phase3, Recruiting
Active & Responsive

A Natural History Study of the Gangliosidoses

for
Tay-Sachs Disease, Sandhoff Disease,
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 0+

Code: NCT00668187

Recruiting
Active & Responsive

Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain

for
Low Back Pain
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18 - 70

Code: NCT04164225

Recruiting
Active & Responsive

RA-PRO PRAGMATIC TRIAL

for
Rheumatoid Arthritis
Location: Eagan MN, Rochester MN, Okemos MI, Carmel IN,
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT04692493

Phase3, Recruiting
Active & Responsive

Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia

for
Cervical Dystonia
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 30+

Code: NCT07245615

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

for
High-Risk Neuroblastoma
Location: Minneapolis MN, Toronto, Aurora CO, Durham NC,
Sponsor: Renaissance Pharma Ltd.

Sex: All

Age: 1 - 18

Code: NCT07549321

Phase2, Phase3, Recruiting
Active & Responsive

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

for
Cytomegalovirus Prophylaxis
Location: Minneapolis MN, Rochester MN, Chicago IL, Ann Arbor MI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07199465

Phase1, Recruiting
Active & Responsive

Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population

for
Pulse Oximeter Validation
Location: Minneapolis MN, Birmingham AL
Sponsor: Owlet Baby Care, Inc.

Sex: All

Age: 0

Code: NCT06771206

Recruiting
Active & Responsive

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

for
Heart Failure, Heart Diseases, Cardiovascular Diseases,
Location: Minneapolis MN, Rochester MN, Iowa City IA,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06526195

Recruiting
Active & Responsive

Assessment of CCM in HF With Higher Ejection Fraction

for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Minneapolis MN, Sioux Falls SD, West Des Moines IA,
Sponsor: Impulse Dynamics

Sex: All

Age: 18+

Code: NCT05064709

Recruiting
Active & Responsive

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

for
Hypertension, Hypertension, Systolic, Hypertension, Essential
Location: Minneapolis MN, Chicago IL, Kansas City KS, Wichita KS,
Sponsor: Orchestra BioMed, Inc

Sex: All

Age: 18+

Code: NCT06059638

Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Minneapolis MN, Sioux Falls SD, Madison WI, Omaha NE,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Minneapolis MN, Fargo ND, West Des Moines IA,
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Minneapolis MN, Chicago IL, Grand Rapids MI, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase3, Recruiting
Active & Responsive

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

for
Non-small Cell Lung Cancer, NSCLC
Location: Minneapolis MN, Chicago IL, Ypsilanti MI, Kitchener,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06422143

Phase3, Recruiting
Active & Responsive

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

for
Opioid Use Disorder
Location: Minneapolis MN, Denver CO, Huntington WV, Boston MA,
Sponsor: Yale University

Sex: All

Age: 18 - 70+

Code: NCT06323824

Recruiting
Active & Responsive

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

for
Glioblastoma
Location: Minneapolis MN, Cleveland OH, Toronto, Aurora CO,
Sponsor: Global Coalition for Adaptive Research

Sex: All

Age: 18+

Code: NCT03970447

Phase2, Phase3, Recruiting
Active & Responsive

Gastroschisis Outcomes of Delivery (GOOD) Study

for
Gastroschisis
Location: Minneapolis MN, Madison WI, Milwaukee WI, Peoria IL,
Sponsor: Medical College of Wisconsin

Sex: Female

Age: 18+

Code: NCT02774746

Recruiting
Active & Responsive

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

for
Lactating Women on Select DOI,
Location: Minneapolis MN, Chicago IL, Pittsburgh PA, Amarillo TX,
Sponsor: Duke University

Sex: All

Age: 0+

Code: NCT03511118

Recruiting
Active & ResponsiveNew

Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

for
Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation,
Location: Minneapolis MN, Chicago IL, Boston MA, Los Angeles CA
Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)

Sex: All

Age: 12 - 17

Code: NCT07286292

Phase2, Recruiting